Inhibitor of proliferation of arterial smooth-muscle cells by fluvastatin [3]

Lancet

Volumn 348, Issue 9041, 1996, Pages 1584-

  Corsini, A ^a   Pazzucconi, F ^a   Pfister, P ^a   Paoletti, R ^a   Sirtori, C R ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FLUINDOSTATIN;

ADULT; AGED; ARTERY MUSCLE; CELL PROLIFERATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; LETTER; MALE; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER;

EID: 0029825999     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)66196-X     Document Type: Letter

References (5)

1. JH Ip V Fuster L Badimon J Badimon MB Taubman JH Chesebro Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation J Am Coll Cardiol 15 1990 1667 1687
2. WA Maltese Posttranslational modification of proteins by isoprenoids in mammalian cells FASEB J 4 1990 3319 3328
3. A Corsini M Raiteri MR Soma F Bernini R Fumagalli R Paoletti Pathogenesis of atherosclerosis and the role of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors Am J Cardiol 76 1995 21A 28A
4. FLS Tse JM Jaffe A Troendle Pharmacokinetics of fluvastatin after single and multiple doses of normal volunteers J Clin Pharmacol 32 1992 630 638
5. JA Herd MS West C Ballantyne J Farmer Gotto AM Jr Baseline characteristics of subjects in the Lipoprotein and Coronary Atherosclerosis Study (LCAS) with fluvastatin Am J Cardiol 73 1994 42D 49D